Last reviewed · How we verify
Hezkue Turbo
At a glance
| Generic name | Hezkue Turbo |
|---|---|
| Also known as | Sildenafil liquid suspension |
| Sponsor | Aspargo Labs, Inc |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male Subject (PHASE1)
- The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects (PHASE1)
- Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hezkue Turbo CI brief — competitive landscape report
- Hezkue Turbo updates RSS · CI watch RSS
- Aspargo Labs, Inc portfolio CI